OZEMPIC FOR WEIGHT LOSS IN DELHI

Ozempic, Wegovy and semaglutide: getting the names right

This matters before anything else, because the confusion causes real problems. Ozempic and Wegovy contain the same active molecule — semaglutide — but they are different products with different licensed uses and different maximum doses.

Ozempic is licensed for type 2 diabetes. Wegovy is the semaglutide product licensed specifically for weight management, at a higher maximum dose. When people search for Ozempic for weight loss, what they usually need is a conversation about which semaglutide product is appropriate for their diagnosis.

Prescribing a diabetes product purely for weight loss, where a weight-management licensed product exists, is a clinical decision that needs proper justification rather than a default. A doctor should explain which one they are recommending and why.

Availability of both products in India has fluctuated with global supply. Your doctor should tell you what is genuinely accessible rather than promising a product they cannot reliably obtain.

How semaglutide works

GLP-1 is a hormone your gut releases after eating. It signals fullness to the brain, slows how quickly the stomach empties, and prompts the pancreas to release insulin when blood glucose rises.

Semaglutide is a GLP-1 receptor agonist — it mimics that hormone but persists far longer in the body, which is why it is a once-weekly injection rather than something taken after every meal.

Published trials of high-dose semaglutide for weight management reported average total body weight reductions of roughly 15% over about 68 weeks, alongside diet and activity support.

Patients consistently describe the same experience: the constant mental background noise about food quietens, and portions that once felt inadequate begin to feel sufficient.

Why semaglutide works when dieting has not

Most patients arriving at our clinic have lost weight before, sometimes repeatedly, and regained it. That pattern reflects how the body defends against weight loss rather than any failure of willpower.

After weight loss, hunger and satiety hormones shift in a direction that promotes intake, and resting metabolic rate falls. These adaptations persist for a long time, which is why maintaining a loss is harder than achieving one.

Semaglutide acts directly on that hormonal signalling, which is why a calorie deficit becomes achievable without the daily willpower battle that defeats most diets.

This reframes obesity as a chronic condition with a biological basis — which is also why it requires medical supervision rather than a retail transaction.

Ozempic versus Mounjaro: which is better?

Mounjaro contains tirzepatide, which activates both GIP and GLP-1 receptors. Semaglutide acts on the GLP-1 receptor alone.

Trial data reflect that difference: average total body weight reductions of roughly 20% at the highest tirzepatide doses over about 72 weeks, against roughly 15% for high-dose semaglutide over about 68 weeks.

That gap is meaningful across a population but does not predict any individual's result. A patient who tolerates semaglutide well may do better on it than on a tirzepatide dose they cannot reach.

Side effect profiles are broadly similar since the mechanism overlaps. Switching between them is a recognised clinical option where response or tolerance is poor, and is a decision for your doctor rather than a preference.

Patient outcomes from supervised programmes at our clinic, published with consent and with faces obscured for privacy. Individual results vary.

Who qualifies for treatment in Delhi

The established framework is a BMI of 30 or above, or 27 or above where a weight-related condition is present — type 2 diabetes, prediabetes, hypertension, high cholesterol, obstructive sleep apnoea, PCOS or fatty liver disease.

For Indian patients this framework needs care. South Asian populations develop metabolic complications at lower BMI than European populations, because of differences in body fat distribution and visceral fat accumulation.

Several guidelines therefore apply lower thresholds for South Asian patients. We assess waist circumference and metabolic markers alongside BMI rather than treating BMI as the sole gatekeeper.

A patient at BMI 28 with central obesity, raised HbA1c and fatty liver is a very different clinical picture from a patient at BMI 28 with entirely normal markers.

Who should not take semaglutide

A personal or family history of medullary thyroid carcinoma, or of Multiple Endocrine Neoplasia syndrome type 2, is an absolute exclusion. This requires knowing your family history, which some patients need to check before their appointment.

A history of pancreatitis rules out treatment. So does pregnancy, breastfeeding, or planned conception in the near term — these medicines are stopped a defined period before conception.

Type 1 diabetes is a different condition and this is not a substitute for insulin. Severe kidney impairment, significant gastrointestinal disease including gastroparesis, and active disordered eating all require a different approach.

If you do not qualify, a doctor should say so plainly and explain what would suit you instead, rather than prescribing anyway. That honesty is the point of an assessment.

What Ozempic and semaglutide cost in Delhi

Semaglutide products are priced by strength, so your monthly cost rises as the dose escalates over the first several months. This is why no honest clinic can quote a single flat figure before assessing you.

Ask specifically what the cost will be at the dose you are likely to need, not just the starting dose. Patients who budget only for month one are frequently caught out around month four, which is a common point of abandonment.

A proper programme includes consultations and scheduled reviews, injection training, a personalised diet plan with dietitian access, side-effect management and guidance on stopping. If a quote covers only the medicine, you are buying a prescription rather than a programme.

Because obesity is chronic, the meaningful figure is annual rather than monthly. Location within Delhi does not change the medicine cost, though consultation fees and how services are bundled vary between clinics.

The three-month semaglutide programme

Rather than a repeat prescription, treatment runs as a structured three-month course combining the medicine with doctor supervision, dietitian support, scheduled reviews and a plan for what happens at the end.

The programme fee covers your semaglutide doses for the three-month period, doctor consultations and reviews, injection training, a personalised diet plan with dietitian access, side-effect management and discontinuation guidance.

Bundling doses into the fee has a clinical justification as much as a commercial one. Buying month by month means the bill rises at every dose increase, and that step-up is the single most common point at which patients stop — losing the progress already made.

Which semaglutide product is appropriate for you is a clinical decision made at assessment. Where weight management is the goal, the product licensed for that indication is generally the right choice rather than a diabetes-licensed product used off-label.

Month one: starting safely on a low dose

Treatment begins at the lowest weekly dose regardless of your weight or your goal. That starting dose exists to build tolerance, not to drive weight loss, which is why month one is not a fair test of whether treatment works for you.

You are taught to self-inject in person and given the chance to practise. The medicine goes into the fat layer just under the skin — abdomen, front of thigh or back of upper arm, rotating the site each week.

Most patients notice appetite changes within one to two weeks, though scale movement in month one is typically modest and partly fluid. That is expected.

Your dietitian sets your protein target and builds your eating plan this month, while intake is still relatively normal and habits are easier to establish.

Month two: reaching an effective dose

By month two you have stepped up at least once and the appetite effect is noticeably stronger. This is usually when a consistent downward trend becomes visible on a four-week trend line.

This is also the month where side effects are most likely to trouble you, which is precisely why managed support is part of the programme rather than something you handle alone.

Clothes frequently change before the scale reflects it, particularly once resistance training begins, because it shifts body composition while adding a small amount of lean mass.

Resistance training two or three times weekly should be established by now — it determines how much of what you lose is fat rather than muscle, which decides whether the result holds afterwards.

Month three: consolidating and deciding what next

By month three most patients are at or near their effective dose and progress becomes more predictable. Metabolic markers commonly improve alongside weight — glucose, HbA1c, blood pressure, triglycerides and liver markers.

Reviews at this stage cover more than the scale: waist measurement, how clothes fit, energy, sleep quality and joint pain all matter, and several patients value those changes more than the weight figure.

The important conversation is what happens next. Published follow-up of semaglutide discontinuation reported participants regaining roughly two thirds of lost weight within about a year without continued support.

That is why discontinuation planning is built into the programme rather than left as an afterthought. Some patients continue, some taper to a maintenance dose, some move to another approach entirely.

Keeping side effects low: the slow-titration approach

Most patients who abandon semaglutide do so because side effects were not managed, not because the medicine failed. That is a supervision problem, and it is largely preventable.

The single most effective measure is a slower dose ladder. Progression happens only at scheduled reviews based on how you tolerated the previous level, never automatically on a fixed calendar.

If you are struggling, the dose holds rather than rises. A hold is a normal clinical tool, not a setback — most patients who pause for a few extra weeks go on to tolerate the next step comfortably, whereas patients pushed upward on schedule frequently stop altogether.

Reaching a lower effective dose you tolerate well is a better outcome than reaching the maximum and abandoning treatment. It also costs less, which matters across a full year.

Practical steps that reduce nausea and constipation

Eat smaller amounts more often rather than three large meals. Stop at the first genuine signal of fullness rather than finishing what is served — on this medicine the feedback is immediate and unpleasant if you do not.

Eat slowly. This single change helps more than almost anything else, because the fullness signal arrives with a delay. Avoid lying down for two hours after eating.

In the two to three days following a dose increase, shift deliberately towards bland, lower-fat food. Khichdi, curd rice, idli, plain dal and steamed vegetables are far better tolerated than a rich meal.

Deliberate hydration through the day and a gradual rather than sudden increase in fibre prevent most constipation. You should receive this guidance before starting, not after calling with a problem.

What results are realistic in three months

Three months covers the titration phase and the beginning of steady progress. It is not long enough to reach the figures quoted from 68-week trials, and any clinic implying otherwise is misleading you.

Published trials of high-dose semaglutide for weight management reported average total body weight reductions of roughly 15% over about 68 weeks. A three-month course sits early on that curve.

Expect modest change in month one, a clear downward trend through month two, and steadier progress in month three as you reach your effective dose.

Metabolic improvements frequently appear within this window even where weight change is moderate, and for patients with prediabetes or fatty liver those often matter more than the scale.

Finding an Ozempic doctor in Delhi

The medicine is chemically identical wherever it is prescribed in Delhi. What differs between providers is the assessment before it, the dose decisions during it, and the nutrition and follow-up around it — and those largely determine whether treatment works for you.

Look for a doctor who assesses before prescribing, offers more than one treatment route, employs qualified dietitians, and tells you honestly when injections are not appropriate. Credentials, case volume and follow-up structure matter far more than marketing.

Dr. Rajat Goel is a Gold Medalist surgeon with more than 25 years in practice, holding MBBS, MS, DNB and MNAMS alongside fellowships including FAIS, FICS, FACS, FMAS, FIAGES, FALS and FIMSA, with international fellowships FMIS (Singapore) and FMBS (Taiwan).

His experience spans over 2000 bariatric procedures and 17000 laparoscopic surgeries, alongside more than 1300 patients supervised on GLP-1 programmes — meaning he can tell you honestly when semaglutide alone is unlikely to be enough for your BMI.

Searching for a weight loss clinic near you in Delhi

Our clinic is at D-1/97, Basement, Lajpat Nagar 1, New Delhi 110024, open Monday to Saturday, 9:00 AM to 5:00 PM.

From South Delhi — Lajpat Nagar, GK-1, GK-2, Defence Colony, CR Park, Nehru Place, East of Kailash, Saket, Green Park, Hauz Khas, Malviya Nagar and Vasant Kunj — the journey is typically 10 to 25 minutes.

Central Delhi, covering Karol Bagh, Connaught Place, Rajendra Place and Patel Nagar, is generally 20 to 30 minutes via the Ring Road or Mathura Road.

Lajpat Nagar station sits on both the Violet Line and the Pink Line, which gives patients from across the city several routing options without driving.

Coverage across East, North and West Delhi

East Delhi — Preet Vihar, Mayur Vihar, Laxmi Nagar, Vivek Vihar, Shahdara and Anand Vihar — is commonly 25 to 35 minutes, usually crossing via the DND or Akshardham.

North Delhi — Rohini, Pitampura, Model Town, Civil Lines, Shalimar Bagh and Ashok Vihar — runs 30 to 40 minutes, with the Ring Road or NH44 being the main routes.

West Delhi — Janakpuri, Rajouri Garden, Punjabi Bagh, Tilak Nagar, Vikaspuri, Paschim Vihar and Dwarka — is typically 25 to 40 minutes, with Dwarka at the longer end.

For patients at the further reaches of any of these zones, video consultation removes the repeat journey for routine dose reviews while keeping the same doctor throughout.

Patients from Gurgaon, Noida, Faridabad and Ghaziabad

Gurugram is typically 35 to 55 minutes via NH48 or MG Road. Noida ranges from 30 minutes for the sectors near the DND to over an hour for the outer expressway sectors.

Faridabad connects directly up Mathura Road in 35 to 50 minutes, and the Violet Line runs from Faridabad straight to Lajpat Nagar with no interchange.

Ghaziabad varies widely — Kaushambi and Vaishali at 35 to 45 minutes, Raj Nagar Extension and Modinagar at 60 to 85.

Across all of these, the pattern that works is one in-person visit for assessment and injection training, then video consultation for most subsequent reviews.

Online consultation: how it actually works

Your first consultation can be conducted by video. Your doctor takes your weight history, reviews your current medications and family history, screens for weight-related conditions, and assesses your suitability.

If treatment is appropriate, you receive a clear recommendation covering which product is suggested and why, the expected cost at your likely dose, and what the programme involves month by month.

Ongoing dose reviews are handled by video for most patients once injection technique is established, with WhatsApp support covering questions that arise between appointments.

If a new symptom needs physical assessment, an in-person visit is arranged specifically for that concern rather than every review defaulting to a clinic trip.

How the dose schedule works

Treatment always begins at the lowest weekly dose, regardless of your weight or your goal. That starting dose exists to let your digestive system adapt before the appetite effect is strengthened. It is not the therapeutic dose.

You remain at each level for a defined period, commonly around four weeks, before an increase is considered. Progression is never automatic — at each review your team assesses weight trend, side effect tolerance and nutritional intake.

If you are struggling, the dose holds rather than rises. A hold is a normal clinical tool, not a setback. Most patients who pause for a few extra weeks go on to tolerate the next step comfortably.

Not everyone reaches the maximum dose, and not everyone needs to. The right dose is the lowest one producing a good result you can tolerate — which also costs less.

Learning to inject at home

You are taught to self-inject in person and given the chance to practise before doing it alone. The medicine goes into the fat layer just under the skin — abdomen, front of thigh, or back of upper arm.

Rotate the site each week rather than using the same spot, which prevents lumps and inconsistent absorption. Let the pen reach room temperature before injecting; cold medicine stings noticeably more, and this single step makes the biggest practical difference.

The needle is very fine, and most patients report the anticipation is considerably worse than the injection itself. Needle anxiety is common and worth raising rather than struggling with silently.

Pens require refrigeration and must never be frozen. A frozen pen is discarded, not thawed and used, regardless of how normal it looks.

What the first month actually feels like

Most patients notice appetite changes within the first one to two weeks. Meals feel adequate sooner, and the background preoccupation with food quietens. That subjective change is the meaningful early signal.

Weight movement in month one is typically modest and partly fluid. Some patients see two or three kilograms, others considerably less. Neither predicts the eventual outcome, because you are still on a starting dose designed to build tolerance.

Side effects are usually most noticeable in the first few days after each injection, then settle. Nausea, reduced appetite and altered bowel habit are expected.

Judging treatment on month one is the single most common avoidable mistake, and the most common reason patients stop before reaching a dose that would have worked.

Months two to six: what to expect

By month two or three you have stepped up at least once and the appetite effect is stronger. This is usually when a consistent downward trend becomes visible on a four-week trend line.

Clothes frequently change before the scale reflects it, particularly if you have started resistance training, which shifts body composition while adding a small amount of lean mass.

Months four to six are typically the steadiest phase. Metabolic markers commonly improve alongside weight — glucose, HbA1c, blood pressure, triglycerides and liver markers.

Many patients report the improvements they value most are not on the scale at all: sleep quality, joint pain, mobility, energy and confidence.

Side effects and how they are managed

The overwhelming majority are digestive: nausea, reduced appetite, constipation, diarrhoea, reflux and burping. They are usually mild to moderate, strongest in the days following a dose increase, and settle as the body adapts.

Practical management works. Eat smaller amounts more often, stop at the first sign of fullness rather than finishing the plate, eat slowly, and avoid fatty or fried food in the days after an increase. Deliberate hydration and gradual fibre prevent most constipation.

Serious effects are uncommon but real. Severe abdominal pain radiating to the back can indicate pancreatitis; severe upper-right abdominal pain may indicate gallbladder disease. Both warrant same-day contact rather than waiting for a review.

You should receive written guidance on which symptoms need urgent contact before you start, along with a route to reach someone outside clinic hours.

Nutrition for Delhi households

When appetite falls sharply, what you eat matters more, not less. You may be eating half of what you previously did, so every meal has to work considerably harder nutritionally.

The specific risk is muscle. Muscle is metabolically active, and losing it lowers your resting energy expenditure, making the result harder to hold once treatment ends. Protein at every meal is the countermeasure, distributed across the day rather than concentrated at dinner.

For Delhi households this means restructuring rather than importing a template: dal, rajma, chole, paneer, curd, eggs, soya and sattu as the centre of the plate rather than accompaniments to a large serving of rice or several rotis.

Resistance training two or three times weekly, scaled to your joints and fitness, does more to preserve lean mass than any amount of cardiovascular exercise.

What happens when you stop

Appetite returns when the medicine is withdrawn. Published follow-up of semaglutide discontinuation reported participants regaining roughly two thirds of lost weight within about a year without continued support.

This is not a failure of the medicine. It reflects that obesity is a chronic condition with a biological basis, in the same way blood pressure rises again after stopping antihypertensives.

It is also why discontinuation should be planned and tapered with increased nutrition support and closer monitoring, rather than simply stopping when a target is reached or supply runs out.

Some patients continue long term, some taper to a maintenance dose, and some move to another approach. That decision is made with your doctor rather than unilaterally.

Warning signs when choosing a clinic

Be cautious of anywhere prescribing injectable medicines without a proper doctor consultation. That is the clearest single indicator of a clinic treating a prescription medicine as a retail product.

Compounded or unbranded semaglutide circulates at lower prices across Delhi. It is not quality-assured, dosing cannot be verified, and regulators in several countries have issued warnings after adverse events. We neither prescribe nor endorse it.

Guaranteed weight loss figures, pressure to buy long prepaid packages on a first visit, no dietitian involvement, and no plan for what happens when treatment ends are all meaningful gaps.

Be particularly wary of anyone offering semaglutide without asking about your thyroid or pancreatitis history — those are the exclusions that matter most, and skipping them is a serious lapse.

When injections are not the right route

At a BMI of 40 and above, or 35 and above with serious weight-related disease, bariatric surgery produces substantially larger and more durable results, and frequently improves type 2 diabetes, sleep apnoea and blood pressure alongside.

For patients wanting a defined, time-limited intervention without surgery, the Allurion swallowable balloon occupies stomach volume for around sixteen weeks with no anaesthesia or endoscopy.

For patients below the treatment threshold, dietitian-led weight management is the appropriate route, and prescribing an injectable would not be.

A clinic offering only injections cannot give you this comparison honestly. We offer four routes, which means we can recommend the least invasive option that will realistically work for you.

Booking your consultation

Book by phone, WhatsApp or through this website. Mention which part of Delhi or NCR you are travelling from and we can advise on appointment timing to avoid the worst of the traffic.

First consultations are available in person at the Lajpat Nagar clinic or by video, whichever suits you. There is no obligation attached to that conversation.

If treatment is appropriate, you will leave knowing which product is recommended and why, what it will cost at your likely dose, and what the programme involves month by month.

If the honest answer is that no treatment is appropriate yet, we will tell you that too.

Frequently asked questions